Insilico Medicine Company
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Investors
.jpg)
.png)
Technology:
Machine Learning
Industry:
Artificial Intelligence, Biotechnology, Genetics, Health Care, Pharmaceutical
Headquarters:
Hong Kong, Hong Kong Island, Hong Kong
Founded Date:
1/1/2014
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
16
Total Funding:
$306,300,000.00
Estimated Revenue:
Less than $1M
Last Funding Date:
6/22/2021
Last Funding Type:
Series C
Register and Claim Ownership